Literature DB >> 4244560

Acne vulgaris. Studies in pathogenesis: triglyceride hydrolysis by Corynebacterium acnes in vitro.

R E Kellum, K Strangfeld, L F Ray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4244560     DOI: 10.1001/archderm.101.1.41

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  8 in total

1.  Lipolytic activity of microorganisms in acne vulgaris.

Authors:  W J Cunliffe; K Strangfeld; K T Holland; C D Roberts; J C Edwards
Journal:  Proc R Soc Med       Date:  1975-05

2.  Prostaglandin-like substances in Propionibacterium acnes.

Authors:  S Abrahamsson; L Hellgren; J Vincent
Journal:  Experientia       Date:  1978-11-15

3.  [Composition of skin surface lipids in persons with seborrhoea sicca and seborrhoea oleosa (author's transl)].

Authors:  M Gloor; J Breitinger; H C Friederich
Journal:  Arch Dermatol Forsch       Date:  1973

4.  [Significance of triglyceride splitting by C. acnes in acne vulgaris (author's transl)].

Authors:  W Hägele; H Schaefer; G Stüttgen
Journal:  Arch Dermatol Forsch       Date:  1973-05-28

5.  [Effect of tetracycline therapy in acne vulgaris on amount and composition of skin surface lipids in various dosages. Gas chromatographic studies of its action mechanism].

Authors:  M Gloor; M Kionke; H C Friederich
Journal:  Arch Dermatol Forsch       Date:  1972

6.  [Influence of tetracycline therapy in acne vulgaris on the quantity and composition of skin surface lipids at varying dosage. I].

Authors:  M Gloor; U Graumann; I Wiegand; H C Friederich
Journal:  Arch Dermatol Forsch       Date:  1972

7.  Tetracycline inhibition of a lipase from Corynebacterium acnes.

Authors:  K Weaber; R Freedman; W W Eudy
Journal:  Appl Microbiol       Date:  1971-04

8.  Propionibacteria as a cause of shunt and postneurosurgical infections.

Authors:  P R Skinner; A J Taylor; H Coakham
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.